1. Addressing current challenges and future directions in immuno-oncology: expert perspectives from the 2017 NIBIT Foundation Think Tank, Siena, Italy

   • Michele Maio
   • George Coukos
   • Ramy Ibrahim

   Opinion Paper 18 December 2018 Pages: 1 - 9

2. β-Adrenergic signaling blocks murine CD8⁺ T-cell metabolic reprogramming during activation: a mechanism for immunosuppression by adrenergic stress

   • Guanxi Qiao
   • Mark J. Bucsek
   • Elizabeth A. Repasky

   Original Article Open access 18 September 2018 Pages: 11 - 22

   

3. Sustained efficacy of adjuvant immunotherapy with cytokine-induced killer cells for hepatocellular carcinoma: an extended 5-year follow-up

   • Jeong-Hoon Lee
   • Joon Hyeok Lee
   • Jung-Hwan Yoon

   Original Article Open access 19 September 2018 Pages: 23 - 32

   

4. TRPM2 modulates neutrophil attraction to murine tumor cells by regulating CXCL2 expression

   • Maya Gershkovitz
   • Tanya Fainsod-Levi
   • Zvi Granot

   Original Article 24 September 2018 Pages: 33 - 43

   

5. CD19⁺ tumor-infiltrating B-cells prime CD4⁺ T-cell immunity and predict platinum-based chemotherapy efficacy in muscle-invasive bladder cancer

   • Qi Jiang
   • Qiang Fu
   • Jiejie Xu

   Original Article 26 September 2018 Pages: 45 - 56

   

6. Serum miRNA-based distinct clusters define three groups of breast cancer patients with different clinicopathological and immune characteristics

   • Sotirios P. Fortis
   • Christoforos K. Vaxevanis
   • Sonia A. Perez

   Original Article 01 October 2018 Pages: 57 - 70

   

7. An autologous dendritic cell vaccine polarizes a Th-1 response which is tumoricidal to patient-derived breast cancer cells

   • Michele Tomasicchio
   • Lynn Semple
   • Keertan Dheda

   Original Article Open access 03 October 2018 Pages: 71 - 83

   

8. Recurrent grade 4 panuveitis with serous retinal detachment related to nivolumab treatment in a patient with metastatic renal cell carcinoma

   • Wei Wang
   • Wai-Ching Lam
   • Ling Chen

   Original Article 11 October 2018 Pages: 85 - 95

   

9. Soluble CTLA-4 as a favorable predictive biomarker in metastatic melanoma patients treated with ipilimumab: an Italian melanoma intergroup study

   • Maria Pia Pistillo
   • Vincenzo Fontana
   • On behalf of the Italian Melanoma Intergroup (IMI)

   Original Article 11 October 2018 Pages: 97 - 107

   

10. Association of IL-36γ with tertiary lymphoid structures and inflammatory immune infiltrates in human colorectal cancer

    • Aliyah M. Weinstein
    • Nicolas A. Giraldo
    • Catherine Sautès-Fridman

    Original Article 12 October 2018 Pages: 109 - 120

    

11. Phase I/II clinical trial of a Wilms’ tumor 1-targeted dendritic cell vaccination-based immunotherapy in patients with advanced cancer

    • Wen Zhang
    • Xu Lu
    • Lin Yang

    Clinical Trial Report 10 October 2018 Pages: 121 - 130

    

12. Fighting breast cancer stem cells through the immune-targeting of the xCT cystine–glutamate antiporter

    • Roberto Ruiu
    • Valeria Rolih
    • Laura Conti

    Focussed Research Review 15 June 2018 Pages: 131 - 141

    

13. The Italian Network for Tumor Bio-Immunotherapy (NIBIT) Foundation: ongoing and prospective activities in immuno-oncology

    • Anna Maria Di Giacomo
    • Alessia Covre
    • Michele Maio

    Focussed Research Review 18 December 2018 Pages: 143 - 150

    

14. Fifteenth Meeting of the Network Italiano per la Bioterapia dei Tumori (NIBIT) on Cancer Bio-Immunotherapy, Siena, Italy, October 5–7, 2017

    • Michele Maio
    • Maria Fortunata Lofiego
    • Vincenzo Russo

    Meeting Report 09 August 2018 Pages: 151 - 158

15. Prediction of neoepitopes from murine sequencing data

    • Anne-Mette Bjerregaard
    • Thomas Kainamura Pedersen
    • Sine Reker Hadrup

    Letter to the Editors 05 October 2018 Pages: 159 - 161